Rambam Maimonides Medical Journal最新文献

筛选
英文 中文
The Role of CCL24 in Systemic Sclerosis. CCL24 在系统性硬化症中的作用
IF 1.4
Rambam Maimonides Medical Journal Pub Date : 2023-07-31 DOI: 10.5041/RMMJ.10504
Hilit Levy, Udi Gluschnaider, Alexandra Balbir-Gurman
{"title":"The Role of CCL24 in Systemic Sclerosis.","authors":"Hilit Levy, Udi Gluschnaider, Alexandra Balbir-Gurman","doi":"10.5041/RMMJ.10504","DOIUrl":"10.5041/RMMJ.10504","url":null,"abstract":"<p><p>Systemic sclerosis (SSc) is a chronic immune-mediated disease characterized by microangiopathy, immune dysregulation, and progressive fibrosis of the skin and internal organs. Though not fully understood, the pathogenesis of SSc is dominated by microvascular injury, endothelial dysregulation, and immune response that are thought to be associated with fibroblast activation and related fibrogenesis. Among the main clinical subsets, diffuse SSc (dSSc) is a progressive form with rapid and disseminated skin thickening accompanied by internal organ fibrosis and dysfunction. Despite recent advances and multiple randomized clinical trials in early dSSc patients, an effective disease-modifying treatment for progressive skin fibrosis is still missing, and there is a crucial need to identify new targets for therapeutic intervention. Eotaxin-2 (CCL24) is a chemokine secreted by immune cells and epithelial cells, which promotes trafficking of immune cells and activation of pro-fibrotic cells through CCR3 receptor binding. Higher levels of CCL24 and CCR3 were found in the skin and sera of patients with SSc compared with healthy controls; elevated levels of CCL24 and CCR3 were associated with fibrosis and predictive of greater lung function deterioration. Growing evidence supports the potency of a CCL24-blocking antibody as an anti-inflammatory and anti-fibrotic modulating agent in multiple preclinical models that involve liver, skin, and lung inflammation and fibrosis. This review highlights the role of CCL24 in orchestrating immune, vascular, and fibrotic pathways, and the potential of CCL24 inhibition as a novel treatment for SSc.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 3","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10026406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remembering Dr Mark/Meir Dvorjetski: Physician, Survivor, Teacher, Historian, and Pioneer of Shoah Medicine Research. 纪念马克/梅尔·德沃杰斯基博士:医生、幸存者、教师、历史学家和大屠杀医学研究的先驱。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-07-31 DOI: 10.5041/RMMJ.10505
Deborah E-S Hemstreet, George M Weisz
{"title":"Remembering Dr Mark/Meir Dvorjetski: Physician, Survivor, Teacher, Historian, and Pioneer of Shoah Medicine Research.","authors":"Deborah E-S Hemstreet,&nbsp;George M Weisz","doi":"10.5041/RMMJ.10505","DOIUrl":"https://doi.org/10.5041/RMMJ.10505","url":null,"abstract":"<p><p>Meir Dvorjetski was a Holocaust survivor, teacher, and historian. He is best remembered for his descriptions of the medicine practiced by the Nazis during World War II, as well as the diseases, disorders, syndromes, and deaths resulting from such practice-particularly, though not solely, on the Jewish race. Dvorjetski's contributions to Holocaust research at Bar-Ilan University in Israel, his underground partisan work, his contributions to society, and his testimony at the Eichmann trial have all been well documented. However, his earlier years-including his survival of the Holocaust, and his less-known medical achievements and contributions to historical records regarding the Holocaust-have not been covered as thoroughly. These latter items are the focus of this paper, with a closing commentary on the relevance of his work for the 21st century.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 3","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10325858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authorship Disputes in Scholarly Biomedical Publications and Trust in the Research Institution. 生物医学学术出版物的作者争议与科研机构的信任。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-07-31 DOI: 10.5041/RMMJ.10503
Itamar Ashkenazi, Oded Olsha
{"title":"Authorship Disputes in Scholarly Biomedical Publications and Trust in the Research Institution.","authors":"Itamar Ashkenazi,&nbsp;Oded Olsha","doi":"10.5041/RMMJ.10503","DOIUrl":"https://doi.org/10.5041/RMMJ.10503","url":null,"abstract":"<p><strong>Introduction: </strong>When authorship disputes arise in academic publishing, research institutions may be asked to investigate the circumstances. We evaluated the association between the prevalence of misattributed authorship and trust in the institution involved.</p><p><strong>Methods: </strong>We measured trust using a newly validated Opinion on the Institution's Research and Publication Values (OIRPV) scale (range 1-4). Mayer and Davies' Organizational Trust for Management Instrument served as control. Association between publication misconduct, gender, institution type, policies, and OIRPV-derived Trust Scores were evaluated.</p><p><strong>Results: </strong>A total of 197 responses were analyzed. Increased reporting of authorship misconduct, such as gift authorship, author displacement within the authors' order on the byline, and ghost authorship, were associated with low Trust Scores (P<0.001). Respondents from institutions whose administration had made known (declared or published) their policy on authorship in academic publications awarded the highest Trust Scores (median 3.06, interquartile range 2.25 to 3.56). Only 17.8% favored their administration as the best authority to investigate authorship dispute honestly. Of those who did not list the administration as their preferred option for resolving disputes, 58.6% (95/162) provided a Trust Score <2.5, which conveys mistrust in the institution.</p><p><strong>Conclusions: </strong>Increased reporting of publication misconducts such as gift authorship, author displacement within the order of the authors' byline, and ghost authorship was associated with lower Trust Scores in the research institutions. Institutions that made their policies known were awarded the highest Trust Scores. Our results question whether the research institutions' administrations are the appropriate authority for clarifying author disputes in all cases.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 3","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10026413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Risk of Rectal Temperature Measurement in Neutropenia. 中性粒细胞减少症患者直肠测温的风险。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-07-31 DOI: 10.5041/RMMJ.10501
Judith Olchowski, Noa Zimhony-Nissim, Lior Nesher, Leonid Barski, Elli Rosenberg, Iftach Sagy
{"title":"The Risk of Rectal Temperature Measurement in Neutropenia.","authors":"Judith Olchowski,&nbsp;Noa Zimhony-Nissim,&nbsp;Lior Nesher,&nbsp;Leonid Barski,&nbsp;Elli Rosenberg,&nbsp;Iftach Sagy","doi":"10.5041/RMMJ.10501","DOIUrl":"https://doi.org/10.5041/RMMJ.10501","url":null,"abstract":"<p><strong>Background: </strong>Avoiding rectal thermometry is recommended in patients with neutropenic fever. Permeability of the anal mucosa may result in a higher risk of bacteremia in these patients. Still, this recommendation is based on only a few studies.</p><p><strong>Methods: </strong>This retrospective study included all individuals admitted to our emergency department during 2014-2017 with afebrile (body temperature <38.3°C) neutropenia (neutrophil count <500 cells/microL) who were over the age of 18. Patients were stratified by the presence or absence of a rectal temperature measurement. The primary outcome was bacteremia during the first five days of index hospitalization; the secondary outcome was in-hospital mortality.</p><p><strong>Results: </strong>The study included 40 patients with rectal temperature measurements and 407 patients whose temperatures were only measured orally. Among patients with oral temperature measurements, 10.6% had bacteremia, compared to 5.1% among patients who had rectal temperature measurements. Rectal temperature measurement was not associated with bacteremia, neither in non-matched (odds ratio [OR] 0.36, 95% confidence interval [CI] 0.07-1.77) nor in matched cohort analyses (OR 0.37, 95% CI 0.04-3.29). In-hospital mortality was also similar between the groups.</p><p><strong>Conclusions: </strong>Patients with neutropenia who had their temperature taken using a rectal thermometer did not experience a higher frequency of events of documented bacteremia or increased in-hospital mortality.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 3","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10334921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Can Jewish and Non-Jewish People Collaborate to Improve Healthcare in the US? Considering Community, Autonomy, and Solidarity. 犹太人和非犹太人如何合作改善美国的医疗保健?考虑社区、自治和团结。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-07-31 DOI: 10.5041/RMMJ.10502
Zackary Berger
{"title":"How Can Jewish and Non-Jewish People Collaborate to Improve Healthcare in the US? Considering Community, Autonomy, and Solidarity.","authors":"Zackary Berger","doi":"10.5041/RMMJ.10502","DOIUrl":"https://doi.org/10.5041/RMMJ.10502","url":null,"abstract":"<p><p>The coronavirus 2019 (COVID) pandemic has highlighted the ways in which municipal, state, and Federal agencies in the USA have failed to address the inequities of present-day health systems. As alternative organizing centers outside these agencies, local communities are potentially situated to redress the inequities of present-day health systems in a collaborative manner that demonstrates solidarity by supplementing a purely scientific model of medicine and healthcare. In the mid-twentieth century, the Black Panthers, a revolutionary African American nationalist organization that focused on socialism and self-defense, introduced highly influential free clinics, which sought to bring expertise to the Black community on their own terms. This required bringing the benefits of biomedicine to those who customarily had not seen them. By extension, their approach raises questions regarding community- and expertise-centered approaches for the Jewish community: how is it engaged in healthcare for itself (in its diverse subcategories) and for others? Moreover, understanding how the Jewish community has been ill-served by present-day health-care systems might spur Jewish institutions to reimagine how healthcare should work.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 3","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9956971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment. 巨细胞动脉炎:诊断、监测和治疗的最新技术。
IF 1.4
Rambam Maimonides Medical Journal Pub Date : 2023-04-30 DOI: 10.5041/RMMJ.10496
Abid Awisat, Shiri Keret, Amal Silawy, Lisa Kaly, Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Aniela Shouval, Doron Rimar, Gleb Slobodin
{"title":"Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment.","authors":"Abid Awisat, Shiri Keret, Amal Silawy, Lisa Kaly, Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Aniela Shouval, Doron Rimar, Gleb Slobodin","doi":"10.5041/RMMJ.10496","DOIUrl":"10.5041/RMMJ.10496","url":null,"abstract":"<p><p>Giant cell arteritis (GCA) is the most prevalent subtype of vasculitis in adults. In recent years, there has been substantial improvement in the diagnosis and treatment of GCA, mainly attributed to the introduction of highly sensitive diagnostic tools, incorporation of modern imaging modalities for diagnosis and monitoring of large-vessel vasculitis, and introduction of highly effective novel biological therapies that have revolutionized the field of GCA. This article reviews state-of-the-art approaches for the diagnosis, monitoring, and treatment options of GCA.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 2","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9373334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines-Insights from Rheumatologists. 在糖皮质激素引起的骨质疏松预防指南中钙和维生素D补充的实施-风湿病学家的见解。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-04-30 DOI: 10.5041/RMMJ.10497
Alexandra Balbir-Gurman, Tal Gazitt, Joy Feld, Devy Zisman
{"title":"Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines-Insights from Rheumatologists.","authors":"Alexandra Balbir-Gurman,&nbsp;Tal Gazitt,&nbsp;Joy Feld,&nbsp;Devy Zisman","doi":"10.5041/RMMJ.10497","DOIUrl":"https://doi.org/10.5041/RMMJ.10497","url":null,"abstract":"<p><p>Glucocorticosteroid-induced osteoporosis (GIO) is the most common cause of secondary osteoporosis but is underdiagnosed and undertreated. Our aim in this communication is to review the literature on the implementation of current GIO prevention practices such as calcium and vitamin D supplementation with emphasis on the rheumatologists' perspective relating to the need for development of novel GIO educational prevention measures.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9373336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basic Lessons From India on Vaccination [Letter to the Editor]. 印度在疫苗接种方面的基本经验[给编辑的信]。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-04-30 DOI: 10.5041/RMMJ.10499
Thorakkal Shamim
{"title":"Basic Lessons From India on Vaccination [Letter to the Editor].","authors":"Thorakkal Shamim","doi":"10.5041/RMMJ.10499","DOIUrl":"https://doi.org/10.5041/RMMJ.10499","url":null,"abstract":"The personal reflections of Peter Hotez regarding the triple threats of illness, antiscience, and anti-Semitism indicate a shocking state of affairs, reveal¬ing the dark and sinister element of antivaccine activism which must be surmounted. This letter addresses basic lessons on vaccination from India in a nutshell.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9384425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter From Dr. Thorakkal Shamim. 对Thorakkal Shamim博士来信的回应。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-04-30 DOI: 10.5041/RMMJ.10500
Peter J Hotez
{"title":"Response to Letter From Dr. Thorakkal Shamim.","authors":"Peter J Hotez","doi":"10.5041/RMMJ.10500","DOIUrl":"https://doi.org/10.5041/RMMJ.10500","url":null,"abstract":"Dr. Thorakkal Shamim has written a very interesting letter and comment. It is important to hear details about vaccine hesitancy in different countries or regions.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9366586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological Therapies in Inflammatory Myopathies. 炎症性肌病的生物治疗。
IF 1.5
Rambam Maimonides Medical Journal Pub Date : 2023-04-30 DOI: 10.5041/RMMJ.10495
Abd El Haleem Natour, Shaye Kivity
{"title":"Biological Therapies in Inflammatory Myopathies.","authors":"Abd El Haleem Natour,&nbsp;Shaye Kivity","doi":"10.5041/RMMJ.10495","DOIUrl":"https://doi.org/10.5041/RMMJ.10495","url":null,"abstract":"<p><p>Idiopathic inflammatory myopathies (IIM) are a rare group of disorders that feature progressive immune-mediated skeletal muscle destruction along with skin, lung, and joint involvement. Management of IIMs necessitates glucocorticoid therapy followed by conventional steroid-sparing agents to control disease activity. In the settings of refractory myositis or life-threatening manifestations, e.g. lung involvement or oropharyngeal dysphagia, second-line therapies are needed to minimize disease burden, avoid end-organ damage and steroid toxicity, and decrease mortality. These therapies may include biological disease-modifying antirheumatic drugs (bDMARDs), and to a lesser extent, targeted synthetic disease-modifying antirheumatic drugs (TSD). This article reviews the current use of bDMARDs, e.g. intravenous immunoglobulin and rituximab, and a TSD-Janus kinase inhibitors (JAKI)-along with their indications, efficacy, and safety in managing IIM.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9373332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信